| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Glucagon receptor |
|---|
| Ligand | BDBM50110054 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_72874 |
|---|
| IC50 | 20±n/a nM |
|---|
| Citation |  Ling, A; Plewe, M; Gonzalez, J; Madsen, P; Sams, CK; Lau, J; Gregor, V; Murphy, D; Teston, K; Kuki, A; Shi, S; Truesdale, L; Kiel, D; May, J; Lakis, J; Anderes, K; Iatsimirskaia, E; Sidelmann, UG; Knudsen, LB; Brand, CL; Polinsky, A Human glucagon receptor antagonists based on alkylidene hydrazides. Bioorg Med Chem Lett12:663-6 (2002) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Glucagon receptor |
|---|
| Name: | Glucagon receptor |
|---|
| Synonyms: | GCGR | GL-R | GLR_HUMAN | Glucagon Receptor (GCGR) | Glucagon receptor (GlucR) |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 54026.92 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P47871 |
|---|
| Residue: | 477 |
|---|
| Sequence: | MPPCQPQRPLLLLLLLLACQPQVPSAQVMDFLFEKWKLYGDQCHHNLSLLPPPTELVCNR
TFDKYSCWPDTPANTTANISCPWYLPWHHKVQHRFVFKRCGPDGQWVRGPRGQPWRDASQ
CQMDGEEIEVQKEVAKMYSSFQVMYTVGYSLSLGALLLALAILGGLSKLHCTRNAIHANL
FASFVLKASSVLVIDGLLRTRYSQKIGDDLSVSTWLSDGAVAGCRVAAVFMQYGIVANYC
WLLVEGLYLHNLLGLATLPERSFFSLYLGIGWGAPMLFVVPWAVVKCLFENVQCWTSNDN
MGFWWILRFPVFLAILINFFIFVRIVQLLVAKLRARQMHHTDYKFRLAKSTLTLIPLLGV
HEVVFAFVTDEHAQGTLRSAKLFFDLFLSSFQGLLVAVLYCFLNKEVQSELRRRWHRWRL
GKVLWEERNTSNHRASSSPGHGPPSKELQFGRGGGSQDSSAETPLAGGLPRLAESPF
|
|
|
|---|
| BDBM50110054 |
|---|
| n/a |
|---|
| Name | BDBM50110054 |
|---|
| Synonyms: | 3-Cyano-4-hydroxy-benzoic acid [1-[4-(4-isopropyl-benzyloxy)-3,5-dimethoxy-phenyl]-meth-(E)-ylidene]-hydrazide | 3-Cyano-4-hydroxy-benzoic acid [4-(4-isopropyl-benzyloxy)-3,5-dimethoxy-benzylidene]-hydrazide | CHEMBL152765 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C27H27N3O5 |
|---|
| Mol. Mass. | 473.5204 |
|---|
| SMILES | COc1cc(\C=N\NC(=O)c2ccc(O)c(c2)C#N)cc(OC)c1OCc1ccc(cc1)C(C)C |
|---|
| Structure | 
|
|---|
Search and Browse
